Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. Pharmagen Laboratories, Inc
483
•Pharmagen Laboratories, Inc•August 23, 2013

Pharmagen Laboratories, Inc – FDA 483, Aug 23, 2013

Record Details

The FDA conducted an inspection of Pharmagen Laboratories, Inc., a sterile injectable drug manufacturer located at 30 Buxton Farms Road, Suite 110, Stamford, CT 06905, from August 5 to August 23, 2013. The inspection revealed significant deficiencies across quality systems, facilities, equipment, and testing procedures.

Key observations include: - **Lack of a Quality Control Unit (QCU):** No QCU separate from production exists, with the Pharmacy Manager operating in production and approving product release. There are no written procedures for QCU roles, and procedures lack qualified personnel approval. Several lots (Acetylcysteine, Nalbuphine, Sodium Phosphates, Dextrose PF) were distributed without or prior to release signatures. - **Process Validation Deficiencies:** No process validation for deviations in Dextrose production, including pooling of lots and capping in unclassified areas without hold time data. Deficiencies were noted in testing for repeater pump use, and no microbial retention studies or qualification for product interaction with the pump itself. Media fills lacked growth promotion for prepared media. - **Inadequate Batch Records:** Master batch records are not approved by a QCU. Logged Formula Worksheets lack actual ingredient weights, second verification of components, product yield calculation, and labeling reconciliation. - **Contamination Control Deficiencies:** No smoke studies in classified areas (clean room, horizontal flow hood, isolator), and ISO

Company
Pharmagen Laboratories, Inc
Inspection date
August 23, 2013
Product type
Drugs
Office
New England District Office
People
  • Maya M. Davis (Assuring that quality medicines are available to the American public)
  • Sharon K. Thoma (sharon.thoma@fda.gov)
View Company Profile

ID · d7e03fb0-4fad-4214-b1d7-5be7a300241a

Violation Codes3
21 CFR 21021 CFR 21121 CFR 331(c)

Full citation text and observation details available on the Dashboard.

Other documents for Pharmagen Laboratories, Inc
  • WARNING_LETTER - 2013-08-23August 23, 2013

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Pharmagen Laboratories, Inc
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.